VX-026

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVX-026
Drug Alias NameHLA-A3 polypeptide vaccine (Vaxon)VX-026
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxon Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxon Biotech
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A